may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".
.